GSTM1 and acute myeloid leukemia: Our study showed that the nomogram combining significant clinical hematological indicators (Hb and Plt) with quantitative imaging values (non-enhanced CT values) significantly improved the predictive performance for treatment response in AML, with an AUC of 0.912.